opioids
| 4 min read
Neuroscience discoveries, pharma investments, FOIA requests, and more led the news this week.
| 3 min read
Vertex Pharmaceuticals’ drug, Journavx, blocks a sodium channel outside of the brain. Experts hope that this non-addictive pain drug may be the first of many.
| 5 min read
Researchers studied an antidepressant that may help treat neuropathic pain.
| 4 min read
A promising relationship between acetylcholine signaling and pain relief in mice could point the way to a non-opioid therapeutic.
| 8 min read
New research aims to make antibody drug delivery as precise and efficient as the antibodies themselves.
Available on Demand
Researchers harness pharmacogenomics to understand why individual patients react differently to opioids for pain relief.
| 4 min read
Researchers precisely engineered an antibody to better treat respiratory depression due to overdose from increasingly prevalent synthetic opioids.
Page 1 of 1 - 7 Total Items
